Galantamine extended release in Alzheimer's disease: profile report.
Robinson
Dean M
DM
Wolters Kluwer Health | Adis, Auckland, New Zealand. demail@adis.co.nz
Plosker
Greg L
GL
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000627:therapeutic use*; D005702:Galantamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
D003692:Delayed-Action Preparations; D018697:Nootropic Agents; D005702:Galantamine